Apellis Pharmaceuticals, Inc. (APLS)
40.99
+0.04
(+0.10%)
USD |
NASDAQ |
Apr 28, 16:00
41.00
+0.01
(+0.02%)
After-Hours: 20:00
Apellis Pharmaceuticals Market Cap : 5.240B for April 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 26.91B |
| Eli Lilly & Co. | 780.79B |
| Agios Pharmaceuticals, Inc. | 1.453B |
| Scholar Rock Holding Corp. | 5.368B |
| Kezar Life Sciences, Inc. | 53.89M |
Market Cap Related Metrics
| PE Ratio | 331.90 |
| PS Ratio | 5.188 |
| Price to Book Value | 14.16 |
| Price to Free Cash Flow | 115.69 |
| Price | 40.99 |
| Earnings Yield | 0.30% |
| Operating PE Ratio | 93.96 |
| Normalized PE Ratio | 331.90 |